These results suggest activation PGC-1α regulated the VEGF/VEGFR2 pathway and further promoted MEK/ERK signaling which provided neuroprotective effects against epilepsy, status epilepticus, and neurodegenerative diseases. This evidence concerns the gene MAP2K7 and neurodegenerative disease.